Trump signals willing to work with Republicans on healthcare bill
WASHINGTON - U.S. President Donald Trump acknowledged that a lack of support from four Senate Republicans leaves the party's healthcare overhaul on a "very, very narrow path" to win passage, but signaled a willingness to work with them to make changes.
Novartis breast cancer drug Kisqali wins European panel backing
ZURICH - A European Medicines Agency panel recommended on Friday approving Novartis's Kisqali drug, bolstering the Swiss drugmaker's bid to challenge rival Pfizer's Ibrance against tough-to-treat breast cancer.
Germany's Merck gets EU backing for oral MS drug
FRANKFURT - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral multiple sclerosis drugs in Europe, six years after its first attempt to launch the cladribine pill failed.
EU regulators greenlight U.S. biotech Aveo's kidney cancer drug
- European regulators on Friday recommended the approval of Aveo Pharmaceuticals Inc's drug to treat kidney cancer, marking a big victory for the U.S. biotech that has faced a number of setbacks in bringing the drug to the market.
EU backs second biosimilar copy of Humira, world's top drug
FRANKFURT - European regulators have recommended approval of a second copy of AbbVie's rheumatoid arthritis drug Humira, the world's top-selling medicine, in a further boost for so-called biosimilars in the region.
South Africa reports outbreak of H5N8 bird flu, industry body says
JOHANNESBURG - South Africa reported an outbreak of highly pathogenic H5N8 bird flu at a farm in the Free State province, agricultural industry body group AgriSA said on Friday.
United Nations stresses for support for Haiti cholera fight
PORT-AU-PRINCE, Haiti - The United Nations stressed on Thursday its support for eradicating cholera in Haiti, an epidemic it accidentally started, although the government said residents would be better served if aid funding was channeled through it.
South Africa reports outbreak of H5N8 bird flu, industry body says
JOHANNESBURG - South Africa reported an outbreak of a highly pathogenic H5N8 bird flu at a farm in the Free State province, an agricultural industry body group, AgriSA, said on Friday.
U.S. bans fresh Brazil beef imports over safety concerns
CHICAGO - The United States halted imports of fresh Brazilian beef on Thursday, the U.S. Department of Agriculture said, after a high percentage of shipments failed to pass safety checks.
Two U.S. studies differ over effects of marijuana on drivers
- Two U.S. studies on the effects of marijuana on drivers in states where it is allowed for recreational use came to different conclusions about whether it increases risks behind the wheel.
FDA approves more convenient form of Roche blood cancer drug
- U.S. health regulators on Thursday approved a new formulation of Roche's big-selling cancer drug Rituxan for three common types of blood cancers that allows for relatively quick administration via injection under the skin in place of a lengthy intravenous infusion, the company said.
GSK's new CEO aims to divest sports nutrition brand: sources
LONDON - GlaxoSmithKline Plc's new Chief Executive Officer Emma Walmsley is shaking up the British drugmaker's portfolio of smaller products with plans to divest its MaxiNutrition sports nutrition brand, two people familiar with the matter said on Thursday.
Mylan shareholders vote against executive pay, re-elect board
AMSTERDAM - Mylan NV shareholders voted against the generic drugmaker's executive pay policy but re-elected the board at its annual meeting on Thursday despite a shareholder campaign in the wake of a scandal over high prices for its EpiPen emergency allergy treatment.
Relatives of people with fatty liver cirrhosis also at risk
- If a parent or sibling has cirrhosis due to non-alcoholic fatty liver disease, a person's odds of having liver scarring are more than 12 times higher than for people without close relatives who have this condition, a small study finds.
Obamacare replacement bill takes center stage in Senate
WASHINGTON - A seven-year push by U.S. Republicans to dismantle Obamacare and kill the taxes it imposed on the wealthy will reach a critical juncture on Thursday when Senate Republican leaders unveil a draft bill they aim to put to a vote, possibly as early as next week.
U.N. blames warring sides for Yemen's 'man-made' cholera 'catastrophe'
GENEVA - U.N. humanitarian chief Stephen O'Brien described the cholera outbreak in Yemen, which is fast approaching 300,000 cases, as a "man-made catastrophe" caused by the warring sides in the country's civil war and their international backers.
Novartis heart drug success opens up new care option
ZURICH/LONDON - A Novartis anti-inflammatory drug cut cardiovascular risk for heart attack survivors in a pivotal trial, potentially changing ideas about treatment.
Surprise win for anti-inflammatory heart drug boosts Novartis
ZURICH/LONDON - A Novartis drug designed to reduce inflammation has shown surprising efficacy in cutting cardiovascular risk for people who had survived a heart attack, potentially changing ideas about treatment and boosting the company's shares.
Draft Senate healthcare bill would link subsidies to income: Washington Post
WASHINGTON - Senate Republicans would repeal most of the taxes that pay for Obamacare, roll back expanded Medicaid coverage under the healthcare law approved in 2010, reshape its subsidies, give states wider latitude to opt out of its regulations and eliminate federal funding for Planned Parenthood, ...
Cigna stays in Obamacare for now; Anthem reduces participation
NEW YORK - U.S. healthcare insurer Cigna Corp said on Wednesday it will continue to offer individual coverage under Obamacare for now while rival Anthem Inc announced it was shrinking its participation, amid uncertainty over the fate of the government-subsidized program.
Ohio county claims top spot in America's opioid death spiral
DAYTON, Ohio - Scott Weidle is struggling with the death of his son Daniel, who died from a heroin overdose 18 months ago, one day after Christmas.
Drugmaker Mylan gets boost from unlikely source: coal
NEW YORK - Mylan N.V. is best known for producing EpiPen emergency allergy treatments and generic drugs.
Novartis eye drug works with fewer injections than rival
ZURICH - A Novartis drug to treat a leading cause of vision loss in people over 65 does not need to be injected as frequently as a rival medicine from Regeneron Pharmaceuticals to be effective, clinical trials showed on Tuesday.
Shire's long-acting ADHD drug wins U.S. approval
- The U.S. Food and Drug Administration on Tuesday approved Shire Plc's long-acting therapy for attention deficit hyperactivity disorder , adding another treatment to its stock of drugs for the cognitive condition that affects millions of children.
Worldwide drug sale forecasts fall as pricing pressures mount
LONDON - Forecasts for global sales of pharmaceuticals have declined for the first time in a decade as continuing pressure on prices in the key U.S. market has caused analysts to moderate revenue expectations, according to a report on Tuesday.
Screen kids and teens for obesity, U.S. experts say
- Children and teens should be screened for obesity at doctors' offices starting at age 6 and advised to attend intensive weight management programs if needed, according to a U.S.-government backed panel.
WHO says child from Raqqa among 15 new polio cases in Syria
GENEVA - Fifteen new cases of polio have been confirmed in Syria, including a child who may have caught the disease in Raqqa, the World Health Organization said on Tuesday.
Many Americans taking too much vitamin D
- Nearly one in five U.S. adults are taking supplemental vitamin D, and a growing number are taking excessively high doses linked to an increased risk of fractures, falls, kidney stones and certain cancers, a new study suggests.
Suburban docs and parents are OK talking about food insecurity
- Medical guidelines say pediatricians should always ask families whether they have enough food to eat, but would that line of questioning go over well in suburbia? Yes, it would, two new studies show.
Novartis eye drug works with fewer injections than rivals
ZURICH - A drug developed by Novartis to treat vision loss in people over 65 does not need to be injected as frequently as a rival medicine from Regeneron to be effective, clinical trials showed on Tuesday.
FDA approves new antibiotic to treat serious skin infections
- The U.S. Food and Drug Administration on Monday approved a new treatment for patients with acute bacterial skin infections, made by privately held Melinta Therapeutics.
Most young opioid abusers don't get anti-addiction medicines
- Even as a growing number of U.S. teens and young adults are abusing opioid drugs, only about one in four of them are getting medications to combat addiction, a new study suggests.
Mindfulness-based childbirth classes may ease pain, depression
- When birthing classes include mindfulness-based education instead of focusing only on the biology of having a baby, women may have an easier time coping with labor pain and a lower risk of postpartum depression, a small experiment suggests.
Yoga as good for low back pain as physical therapy
- Chronic lower back pain is equally likely to improve with yoga classes as with physical therapy, according to a new study.
Seattle Genetics halts late-stage study of leukemia drug
- Seattle Genetics Inc said it would halt a late-stage study of its drug to treat a type of leukemia in older patients following a "higher rate" of deaths in patients on the drug compared with those on a placebo.
Nearly 1,300 U.S. kids die from gunshot wounds each year
- Firearms kill almost 1,300 American youngsters each year, and boys and black children are most often the victims, a U.S. study finds.
Occasional smokers who vape smoke more cigarettes
- Tobacco companies have been selling electronic cigarettes as a way to wean smokers off paper cigarettes, but a new study suggests the strategy could backfire.
Clovis's ovarian cancer drug set for label expansion, shares soar
- Positive late-stage data on Clovis Oncology Inc's ovarian cancer drug, Rubraca, could help widen the use of the therapy and differentiate it from rivals, the U.S. biotech said on Monday, sending its shares soaring 48 percent.
Exclusive: Ahead of Modi visit, U.S. lawmakers ask India to rethink price cap on stents
NEW DELHI - A group of U.S. lawmakers has backed medical device makers by urging India to reconsider its decision to cap prices of heart stents, raising the issue ahead of Prime Minister Narendra Modi's visit to the United States later this week.
Israel's Gamida Cell raises $40 million for bone marrow trial
TEL AVIV - Israel's Gamida Cell, which is developing cellular therapies to treat cancer and rare genetic diseases, said on Monday it raised $40 million to finance the advanced trial of its product NiCord to facilitate bone marrow transplants.
Clovis Oncology's cancer drug Rubraca succeeds in key study
- Clovis Oncology Inc said its ovarian cancer drug Rubraca slowed disease progression in a late-stage trial involving patients with various gene mutations who had undergone initial therapy.
New test may turn AZ's Lynparza into precision drug for prostate cancer
LONDON - Scientists have developed a new three-in-one blood test that has the potential to turn AstraZeneca's drug Lynparza into a precision medicine for prostate cancer.
Worldwide, more than 10 percent of young teens are smokers
- Roughly 11 percent of youth aged 13 to 15 around the world use tobacco products like cigarettes and cigars, a global survey of students suggests.
California to give health clinics $20 million to counter possible Trump cuts
WASHINGTON - California on Monday will announce plans to award $20 million in emergency grants to local health and Planned Parenthood clinics in anticipation of possible U.S. healthcare funding cuts, according to State Treasurer John Chiang's office.
Nonprescription prenatal vitamins may be more potent
- Prescription prenatal vitamins may have lower doses of key ingredients like vitamin A, vitamin D, and calcium than nonprescription alternatives, a recent study suggests.
Sleeping-in on weekends linked to lower body weight
- - Catching up on lost sleep over weekends may help people keep their weight down, according to a study in South Korea.
Exercise may stave off postpartum depression
- - Physical activity during and after pregnancy improves psychological wellbeing and may protect against postpartum depression, according to a new analysis of existing research.
More liver cancer deaths could be averted in the U.S
- - Death rates from liver cancer in the U.S. have doubled since the 1980s and continue to rise, largely due to risk factors like hepatitis that should be the focus of better treatment and prevention efforts, researchers say.
China to vaccinate poultry against H7N9 bird flu next month
BEIJING - China has decided to vaccinate poultry from next month against the H7N9 bird flu virus, after it claimed hundreds of lives last winter and caused major damage to the industry.
Sanofi chief says U.S. Supreme Court ruling on biologics has "immediate impact"
PARIS - The U.S Supreme Court decision to speed access to copycat biologics drugs on Monday was expected but has an "immediate impact", Sanofi Chief Executive told Reuters.